Treating and Managing OUD and SUD Series

This series counts toward the new Drug Enforcement Administration (DEA) requirement for PAs treating and managing opioid use disorder (OUD) and substance use disorder (SUD). The series focuses on alcohol use disorder, pain management and opioids, dismantling the stigma, and more.


Changemakers in Addiction Care Creation of Pathways for PAs | 1.25 AAPA Category 1 CME credit
Learning Objectives
  • Recognize the opioid overdose epidemic as an urgent public health emergency that PAs are well-positioned to address
  • Recommend evidence-based medication and harm reduction interventions to treat opioid use disorder
  • Formulate a plan to implement a change in or improvement in the care of people who use drugs
Managing Acute Pain 101: A Toolkit for Successfully Treating Pain in the Emergency Department | 1.00 AAPA Category 1 CME credit
Learning Objectives
  • Identify the common barriers and biases in treating acute pain
  • List the major classes of analgesics used in the ED and describe their mechanisms of action
  • Discuss the advantages, disadvantages, and routes of administration of various analgesics and anesthetics
  • Recognize the value of nonpharmacologic therapeutics in the ED
  • Describe the necessary safety precautions when using parental opioids and performing procedural sedation
Pain Management and Opioids: Balancing Risks and Benefits | 2.00 AAPA Category 1 CME credit
Learning Objectives
  • Accurately assess patients in pain
  • Develop a safe and effective pain treatment plan
  • Identify evidence-based non-opioid options for the treatment of pain
  • Identify the risks and benefits of opioid therapy
  • Recognize behaviors that may be associated with opioid use disorder
Pharmacogenetics in Clinical Practice: Focus on Opioids | 1.00 AAPA Category 1 CME credit
Learning Objectives
  • Describe the impact of pharmacogenetic variations on drug metabolism
  • Predict potential opioid adverse events based on a patient’s pharmacogenetic profile
  • Predict potential opioid drug interactions based on a patient’s pharmacogenetic profile
Recognition and Management of Alcohol Use Disorder | 0.75 AAPA Category 1 CME credit
Learning Objectives
  • Review burden of alcohol use disorder and options for screening
  • Explore outpatient and inpatient detox protocols and how to determine what is the appropriate level of care
  • Identify medications used for assisting with maintenance of sobriety
Stigma is Killing Our Patients: Dismantling the Stigma of Substance Use Disorders | 0.75 AAPA Category 1 CME credit
Learning Objectives
  • Define the three main types of stigma and apply these definitions to the care of people with substance use disorders (SUD)
  • Explore the role of early training in producing and reinforcing stigma of people with SUD
  • Develop strategies and best practices for integrating training related to stigma and bias into health professional education across different settings
  • Describe available tools that can be used to address the current gap in health professional education in stigma and bias for people with substance use disorder
Substance Use Disorders in Primary Care | 1.25 AAPA Category 1 CME credit
Learning Objectives
  • Identify the main components and explain the rationale and research support for SBIRT
  • Discuss medical and social influences on our understanding of substance use
  • Explain the Stages of Change Model for use in SBIRT and understand how to apply the stages of change in clinical practice
  • Provide a brief overview of treatment options and criteria
  • Outline the steps to obtain your X-waiver through the Provider Clinical Support System

AAPA offers no returns or refunds for online CME activities purchased via the AAPA store. All sales are final.